SAGRIOK Trademark

Trademark Overview

On Tuesday, May 11, 2010, a trademark application was filed for SAGRIOK with the United States Patent and Trademark Office. The USPTO has given the SAGRIOK trademark a serial number of 85035010. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 6, 2020. This trademark is owned by Glaxo Group Limited. The SAGRIOK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
sagriok

General Information

Serial Number85035010
Word MarkSAGRIOK
Filing DateTuesday, May 11, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 6, 2020
Registration Number4503828
Registration DateTuesday, April 1, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 6, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Friday, November 6, 2020CANCELLED SEC. 8 (6-YR)
Monday, April 1, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 1, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, February 25, 20141(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, January 31, 2014NOTICE OF ALLOWANCE CANCELLED
Friday, January 31, 2014TEAS DELETE 1(B) BASIS RECEIVED
Saturday, August 10, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 9, 2013EXTENSION 5 GRANTED
Wednesday, August 7, 2013EXTENSION 5 FILED
Wednesday, August 7, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 1, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 31, 2013EXTENSION 4 GRANTED
Wednesday, January 30, 2013EXTENSION 4 FILED
Wednesday, January 30, 2013TEAS EXTENSION RECEIVED
Tuesday, August 7, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 6, 2012EXTENSION 3 GRANTED
Thursday, August 2, 2012EXTENSION 3 FILED
Thursday, August 2, 2012TEAS EXTENSION RECEIVED
Friday, February 17, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 16, 2012EXTENSION 2 GRANTED
Monday, January 23, 2012EXTENSION 2 FILED
Thursday, February 16, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 23, 2012TEAS EXTENSION RECEIVED
Thursday, July 28, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 26, 2011EXTENSION 1 GRANTED
Tuesday, July 26, 2011EXTENSION 1 FILED
Tuesday, July 26, 2011TEAS EXTENSION RECEIVED
Tuesday, February 15, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 21, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 21, 2010PUBLISHED FOR OPPOSITION
Wednesday, November 17, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 9, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 5, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 5, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 5, 2010ASSIGNED TO LIE
Wednesday, October 20, 2010TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, August 25, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, August 25, 2010LETTER OF SUSPENSION E-MAILED
Wednesday, August 25, 2010SUSPENSION LETTER WRITTEN
Tuesday, August 24, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, August 24, 2010LETTER OF SUSPENSION E-MAILED
Tuesday, August 24, 2010SUSPENSION LETTER WRITTEN
Tuesday, August 24, 2010ASSIGNED TO EXAMINER
Friday, May 14, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 14, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

sagriok pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic